M&A Ophthalmology Deals Continue Into 2023 with Small And Mid-Size Transactions
The first quarter of 2023 delivered ten reported ophthalmology practice acquisitions, which aligns with seasonal acquisition trends (Q1 of 2022 reported eleven deals).
OPHTHALMOLOGY: A Great Time for Sellers to Do a Deal
The ophthalmology sector continues to be a robust market entering Q2 2023. There are more than 25 core private equity platforms within ophthalmology, plus smaller regional PE-backed groups. Read more here.
EBITDA Valuations Explained
Do you know what two factors drive the most value in your practice sale? How are practices even valued by private equity investors? Hear it directly from one of our seasoned investment bankers.
The Winning Team
A solid team is the key to a successful transaction.
What We Love About Ophthalmology
Ophthalmology M&A has been very active. All of FOCUS' recent transactions have been with private-equity backed buyers.
Plastic Surgery & Aesthetics – A New PE Darling We Should Have Noticed Sooner
The plastic surgery and aesthetics space is showing signs of increasing private equity activity.
FOCUS Investment Banking Represents The Retina Eye Center in its Sale to Retina Consultants of America
Washington, DC, (August 17, 2022) – FOCUS Investment Banking (“FOCUS”), a ...
FOCUS Investment Banking Represents Lee Eye Center in its Sale to Midwest Vision Partners
Washington, DC, (August 4, 2022) – FOCUS Investment Banking (“FOCUS”), a ...
Private Equity’s Interest in Interventional Pain Management Practices
Private equity investors are becoming increasingly interested in interventional pain management practices.
Cardiology May be The Next Big Thing in Physician Practice Management
Investor interest in cardiovascular services is growing, and doctors sense an opportunity.
